LEGN Competitors & Alternatives
Compare Legend Biotech Corp with similar stocks in the same industry
Biotechnology
LEGN
Main Stock$28.67
Tradestie Score
59
Market Cap
$6.03B
Revenue Growth
0.6%
Analyst Upside
+99.6%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABVX
Abivax SA American Depositary Shares
|
$121.91
|
$6.38B | - | 56 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$52.75
|
$6.02B | - | 54 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$105.22
|
$5.95B | - | 55 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$235.32
|
$5.92B | - | 55 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$42.65
|
$5.80B | 15.1 | 57 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$312.58
|
$5.20B | 41.8 | 62 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$54.25
|
$4.94B | - | 52 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$73.46
|
$4.93B | - | 58 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$77.88
|
$4.84B | - | 58 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
More LEGN Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry